Följ Umeå Biotech Incubator

Pressmeddelanden Visa alla 27 träffar

Lipigon attracts SEK 16.6 Million in new investment round to fight cardiovascular disease

Lipigon attracts SEK 16.6 Million in new investment round to fight cardiovascular disease

Pressmeddelanden   •   Jul 02, 2020 08:15 CEST

Lipigon Pharmaceuticals has attracted SEK 16.6 Million in a new share issue that will help it get nearer to its goal of reducing the number of global deaths caused by cardiovascular disease. “We are proud our new shares issue was oversubscribed, particularly during the ongoing Coronavirus pandemic when many investors are feeling more cautious,” says Stefan K Nilsson, CEO.

QureTech Bio has secured a US patent for tuberculosis treatment

QureTech Bio has secured a US patent for tuberculosis treatment

Pressmeddelanden   •   Jun 22, 2020 08:22 CEST

Umeå-based QureTech Bio has received preliminary approval for a patent application in the US for a drug candidate that helps treat tuberculosis. “The US is a key market for us so this news really helps strengthen our position. We are at a very exciting stage right now,” says Fredrik Almqvist, CEO of QureTech Bio.

Key appointments being made at new diabetes vaccine facility in Umeå

Key appointments being made at new diabetes vaccine facility in Umeå

Pressmeddelanden   •   Jun 18, 2020 08:04 CEST

Construction of Diamyd Medical's new vaccine manufacturing unit in Umeå is now underway, with a number of key roles being actively recruited to help staff the new facility. Newly-appointed site manager Maja Johansson is responsible for establishing the process for the production of GAD, the active substance in the study drug Diamyd.

HiloProbe attracts millions in new investment round

HiloProbe attracts millions in new investment round

Pressmeddelanden   •   Jun 10, 2020 08:31 CEST

Umeå biotech company HiloProbe has attracted millions in new investment capital after successfully developing a diagnostic and prognostic product for colon and rectal cancer. “Capital is crucial for getting our product to patients and helping them,” says Lina Olsson, HiloProbe’s CEO.